第一种被证实治疗非霍奇金淋巴瘤安全有效的单克隆抗体———美罗华(Ｍａｂｔｈｅｒａ)在中国上市。这标志着我国在使用基因药物治疗癌症的征程上又迈进了一大步。美罗华是由瑞士罗氏制药公司生产的、针对ＣＤ20抗原的单克隆抗体,它能奇迹般地识别出此种抗原,并与之结合,通过人 The first monoclonal antibody to be proven safe and effective in the treatment of non-Hodgkin’s lymphoma - MabThera is available in China. This marks another major step forward in our country’s use of genetic drugs to treat cancer. Rituximab, a monoclonal antibody to CD20 antigen produced by Roche Pharmaceuticals of Switzerland, miraculously recognizes and binds this antigen